Page last updated: 2024-08-24

trofosfamide and Genetic Predisposition

trofosfamide has been researched along with Genetic Predisposition in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, Z; Jiang, Y; Li, Y; Liang, X; Sun, S; Wang, W; Xie, X; Yang, D; Yuan, P1
Chen, Q; Han, R; Hu, H; Tao, W; Wang, C; Wen, XY1
Bufalo, NE; Leite, JL; Romaldini, JH; Santos, RB; Ward, LS1

Reviews

1 review(s) available for trofosfamide and Genetic Predisposition

ArticleYear
SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.
    The Prostate, 2010, Feb-01, Volume: 70, Issue:2

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Case-Control Studies; Cyclophosphamide; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Genetic; Prostatic Neoplasms

2010

Other Studies

2 other study(ies) available for trofosfamide and Genetic Predisposition

ArticleYear
Bi-allelic recessive loss-of-function mutations in FIGLA cause premature ovarian insufficiency with short stature.
    Clinical genetics, 2019, Volume: 95, Issue:3

    Topics: Adolescent; Alleles; Basic Helix-Loop-Helix Transcription Factors; Consanguinity; Cyclophosphamide; Dwarfism; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Loss of Function Mutation; Pedigree; Phenotype; Primary Ovarian Insufficiency; Whole Genome Sequencing

2019
Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease.
    European journal of endocrinology, 2010, Volume: 162, Issue:2

    Topics: Adult; Autoimmunity; Case-Control Studies; Cyclophosphamide; Cytochrome P-450 CYP1A1; Female; Genetic Predisposition to Disease; Glutathione S-Transferase pi; Glutathione Transferase; Graves Disease; Herpesvirus 7, Human; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Regression, Psychology; Risk Factors; Roseolovirus Infections; Tumor Suppressor Protein p53; Young Adult

2010